Conducting Human Research in public and private settings

Logo
HRSO Inc.
Organisme d'élaboration de normes:
Numéro de référence:
CAN/HRSO-300.01-2020
Catégorie de norme:
National Standard of Canada - Domestic
Type d’activité d’élaboration de normes:
New Standard
Code ICS:
03.100.40
Statut:
Proceeding to development
Date de début de la période de commentaires OEN:
Date de fin de la période de commentaires des OEN:
Affiché le:

Porté:

Champ d’application

This standard applies to all organizations, public and private, engaged in the conduct of human research, including hospitals, universities, academic health centres, and clinics. Human research is defined as a systematic, scientific investigation involving human beings as research participants. Human research can be interventional (eg clinical research involving a test article), observational (eg behavioural studies that do not involve a test article), or an analysis of existing human research data or human specimens. Human researchers are commonly referred to as investigators and include physicians, dentists, psychologists, engineers, scientists, and all other individuals involved in the research process.

Raison d’être du projet

Raison d’être du projet
One of the primary ethical justifications for conducting human research is to benefit society. Because human research seeks to understand something not yet known, participation in human research is not without risks. Given the fundamental importance of human research, society must ensure that research is conducted ethically, scientifically, safely, and in a manner that safeguards the rights and welfare of research participants. The necessity for a national standard for the conduct of human research is of paramount importance given the narrow focus of the current Canadian regulations. Canada’s Food and Drugs Act and applicable Regulations incorporate an internationally-accepted good clinical practice guideline. The guideline describes best practices for the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of clinical trials. There are two main deficiencies with this guideline: (i) it only applies to interventional (clinical) research, and (ii) its main focus is on the production of credible and accurate research data, and does not fully describe practices for the protection of human research participants. Verifying the quality of the research conducted at an investigative site requires harmonized procedures derived from a well-developed standard. Adherence to this standard will ensure that the investigative site has the requirements necessary to safeguard the rights and welfare of research participants, safely conduct the research, measure the investigative site’s efficiency and performance, and produce reliable, verifiable and credible data in an efficient and low-risk environment.

Note : L’information ci-dessus a été recueillie et est diffusée par le Conseil canadien des normes (CCN) pour les besoins de son système de notification centralisé et transparent pour l’élaboration de nouvelles normes. Le système permet aux organismes d’élaboration de normes (OEN) accrédités par le CCN et aux membres du public d’être informés des nouveaux travaux d’élaboration de normes au Canada. Il donne aussi aux OEN accrédités la possibilité de repérer et de résoudre les cas de doubles emplois éventuels dans les normes et les travaux de normalisation.

Les OEN sont eux-mêmes responsables du contenu et de l’exactitude de l’information présentée ici. Cette information n’existe que dans la langue dans laquelle elle a été fournie au CCN.